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Faiz and colleagues show that self-
renewing, multipotent neural stem cells in
the subventricular zone leave their niche
and migrate to the site of injury following
stroke. These migratory stem cells give
rise to reactive astrocytes that contribute
to astrocyte scar formation.
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Reactive astrocytes (RAs) have been reported to
convert to multipotent neural stem cells (NSCs)
capable of neurosphere (NS) formation andmultiline-
age differentiation in vitro. Using genetic tagging,
we determined that subventricular zone (SVZ) NSCs
give rise to NSs derived from the stroke-injured cor-
tex. We demonstrate that these cells can be isolated
from the cortex in two different models of stroke and
from different stroke-lesioned cortical regions. Inter-
estingly, SVZ NSCs give rise to a subpopulation of
RAs in the cortex that contribute to astrogliosis and
scar formation. Last, we show that these SVZ derived
RAs can be converted to neurons in vivo by forced
expression of Ascl1. Identifying the contribution of
cells originating from the SVZ to injury repair has
implications for neural regeneration strategies.
INTRODUCTION
The adult mammalian brain contains a population of neural
stem cells (NSCs) in the subventricular zone (SVZ) that express
NESTIN and glial fibrillary acidic protein (GFAP). Adult NSCs
give rise to neuroblasts, which migrate to the olfactory bulb
and generate new neurons (Lois and Alvarez-Buylla, 1994).
Following brain injury, these neuroblasts can migrate to the
lesion site (Arvidsson et al., 2002) following cues released by
cells at the injury including reactive glia (Leong and Turnley,
2011). Nevertheless, the brain remains limited in its ability to
generate new neurons after injury.
Reactive astrocytes (RAs) are a heterogeneous population of
cells (Molofsky et al., 2012) that play key roles in the CNS
response to injury, such as restricting inflammation, preventing
neuronal loss, and repairing the blood brain barrier (Burda and
Sofroniew, 2014). Recently, two types of RAs have been defined
based on their structural properties: (1) newly proliferated elon-
gated astrocytes that express progenitor markers such as
SOX2, brain lipid binding protein (BLBP), and RC2, and (2)624 Cell Stem Cell 17, 624–634, November 5, 2015 ª2015 Elsevier Instellate astrocytes that derive from resident cortical astrocytes
(Wanner et al., 2013). It has also been suggested that a subset
of RAs has the potential to convert to multipotent, self-renewing
NSCs capable of NS formation in vitro (Buffo et al., 2008; Shi-
mada et al., 2012). However, a recent study has described a sub-
population of RAs originating from the SVZ that migrate to the
damaged tissue and are distinct from resident RAs in a postnatal
mouse model of hypoxia/ischemia (Benner et al., 2013). This led
us to investigate with genetic tools: (1) the origin of cortical neu-
rospheres in two models of stroke, and (2) the contribution of
SVZ cells to the astrogliosis that is seen following brain injury.
Lineage tracking using tamoxifen inducible Nestin-CreERT2
(Imayoshi et al., 2006; Lagace et al., 2007) andCre conditional re-
porter (Madisen et al., 2010; Srinivas et al., 2001) transgenic mice
revealed that cortical NSs originate from SVZ-derived NSCs that
migrate to the stroke lesion after injury. These cortical SVZ-
derived cells rapidly differentiate and give rise to a subpopulation
of RAs that contribute to the astrocyte scar, thus highlighting a
role for the SVZ in post injury gliosis. Last, we demonstrate that
the transcription factor Ascl1 (also known asMash1) can convert
SVZ derived RAs to neurons, providing a new target for cellular
conversion strategies aimed at enhancing neurogenesis.
RESULTS
Neurosphere Forming Capacity of Cells in the Injured
Cortex
To detect NSCs in the injured adult cortex, we performed the
NS assay on tissue derived from the injured cortex and the
SVZ (Figure 1A) of mice 4 days after an endothelin-1 (ET-1)
induced stroke. Similar to previous reports (Buffo et al., 2008;
Erlandsson et al., 2011; Shimada et al., 2012), NSs formed
from the SVZ and stroke-injured cortex (Figures 1B and 1C),
but never from the contralateral (uninjured) cortex (Figure 1C).
While the average size of cortex-derived NSs (ctxNSs) was
less than SVZ derived NSs (svzNSs) (Figure S1A), both popu-
lations displayed the cardinal properties of stem cells; self-
renewal and multipotency (Potten and Loeffler, 1990). Single
NS passaging revealed extended self-renewal (up to passage
5, the longest time examined) with no difference in NS number
at each passage (Figure S1B). Furthermore, ctxNSs and svzNSsc.
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Figure 1. Migratory SVZ Cells Give Rise to Neurospheres in the Stroke-Injured Cortex
(A) Experimental design for cortical NS culture.
(B) SVZ derived and cortical derived NSs (svz and ctx).
(C) Number of NSs formed from the uninjured and stroke-injured cortex and SVZ (** = p = 0.001, unpaired t test with Welch’s correction, t(8) = 5.006, data
represent ±SEM, nctx = 11 mice, and nsvz = 9 mice).
(D) Diagram of injection sites lateral and caudal to the original sensory-motor cortex lesion site.
(E) Number of NSs formed from the cortex and SVZ in lesions lateral and caudal to the original sensory-motor cortex lesion (smctx) and after PVD (*** = p < 0.001,
unpaired t test, t(12) = 9.785, data represent ±SEM, nsmctx_ctx = 9 mice, nsmctx_SVZ = 5 mice; *** = p < 0.001, unpaired t test, t(6) = 8.454, data represent ±SEM,
nlat_ctx = 4 mice, nlat_SVZ = 4 mice; * = p < 0.05, unpaired t test, t(4) = 3.908, data represent ±SEM, ncaud_ctx = 3 mice, ncaud_SVZ = 3 mice; and * = p < 0.05, unpaired
t test, t(12) = 2.978, data represent ±SEM, nPVD_ctx = 7 mice, nPVD_SVZ = 7 mice).
(F) Number of NSs at passage 4 and passage 10 from the original sensory-motor cortex lesion, lateral, and caudal to that site and after PVD (n.s., unpaired t test,
t(5)passage4_et-1 = 0.1879, t(11)passage10_et-1 = 1.1016, t(12)passage4_PVD = 0.3755, t(10) passage10_PVD = 1.910, t(3) passage4_lat = 0.07205, t(2) passage10_late = 0.112,
(legend continued on next page)
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weremultipotent (Figure S1C), with similar differentiation profiles
(Figure S1D). We asked if these findings were specific to the site
of cortical injury or the model of stroke. In a first series of exper-
iments, we assessed NS formation in response to ET-1 strokes
in different regions of the cortex. NSs formed from the stroke-
injured cortex at lesion sites both lateral (Figures 1D and 1E)
and caudal (Figures 1D and 1E) to the sensory-motor cortex
lesions originally examined, revealing that the response was
not regionally specific within the cortex. In a second series of
experiments, we used a different model of stroke, pial vessel
disruption (PVD) (Hua and Walz, 2006; Kolb et al., 2007). PVD
to the sensory-motor cortex resulted in the generation of cortical
derived NSs, identical to what was observed with ET-1 stroke
(Figure 1E). Bulk passaging showed that, akin to our original
stroke paradigm, NSs from lateral, caudal, and PVD stroke sites
showed extended passaging (up to Passage 10, the longest time
examined), with no difference in NS number between ctxNSs
and svzNSs (Figure 1F). Further, no difference was seen in the
percent of multipotent ctxNSs versus svzNSs (Figure S1E).
Cortical Derived Neurospheres Are Derived from
Migratory SVZ Stem Cells
With the goal of distinguishing between ctxNSs and svzNSs, we
took advantage of the Nestin-CreERT2;tdTomatofl double trans-
genic mouse (Imayoshi et al., 2006; Lagace et al., 2007), which
enables permanent tdTOMATO labeling of cells expressing
NESTIN during the time of Cre recombinase induction with
tamoxifen. NESTIN is expressed by neural stem and progenitor
cells in vivo (Morshead et al., 1994). We crossed these animals
with hGFAP-GFPmice that permit visualization ofGFAPexpress-
ing astrocytes andNSCs (Zhuo et al., 1997). TheNestin-CreERT2;
tdTomatofl;hGFAP-GFP triple transgenic mice were fed tamox-
ifen for 2 weeks and chased for 2–3 weeks (Figure 1G), ensuring
labeling ofSVZcellswith tdTOMATOandeliminating thepossibil-
ity of tamoxifen uptake by RAs that express NESTIN after stroke
(Clarke et al., 1994). Tamoxifen fed triple transgenic mice gave
rise to GFP+/tdTOMATO+ svzNSs, while the unfed mice gave
rise to GFP+/tdTOMATO svzNSs (Figure S1F). Most striking,
all of the ctxNSs from stroke lesioned, tamoxifen fed Nestin-
CreERT2;tdTomatofl;hGFAP-GFP mice were GFP+/tdTOMATO+
(Figure 1G) compared to the control unfed mice, where none of
the ctxNSs expressed tdTOMATO. Based on the total number
of cells we isolated from the stroke-lesioned site, we estimate
that approximately 35 ctxNS forming cells are found in the injured
cortex at 4 days post stroke. We repeated this experiment in a
second strain of Nestin-CreERT2 mice (Lagace et al., 2007) to
ensure that the findingswere not the result of tamoxifen indepen-
dent tdTOMATOexpression (Imayoshi et al., 2006) or recombina-t(4) passage4_caud = 1.349, t(4) passage10_caud = 0.9843, data represent ±SEM, nP
nP10_lat_ctx = 2, nP4_caud_ctx = 2, nP10_caud_ctx = 2, nP4_et1_SVZ = 4, nP10_et1_SVZ = 7, nP
and nP10_caud_SVZ = 4, 3 independent trials).
(G) Lineage tracing of SVZ cells using Nestin-CreERT2;tdTomatofl;hGFAP-GFP m
(H) Lineage tracing of SVZ cells using Nestin-CreERT2;YFPfl mice. The pictures s
(I) YFP expression in ctxNSs from stroke sites lateral and caudal to the original s
(J) AraC ablation paradigms.
(K) Number of ctxNSs and svzNSs after AraC ablation (** = p < 0.01, *** = p < 0.001,
from (days, d) nsaline = 8, n14dAraC = 4, and n10dAraC = 2.
(L) KI-67 positive cells in the cortex (uninjured = uninj, injured = inj, subventricular
motor cortex = smctx, PVD, lateral = lat, caudal = caud, tdTOMATO = TOM, and
626 Cell Stem Cell 17, 624–634, November 5, 2015 ª2015 Elsevier Intion in NESTIN negative cells (Sun et al., 2014). Nestin-CreERT2
mice were crossed with a YFPfl Cre conditional reporter and fed
tamoxifen for 2 weeks, followed by a 2–3 week chase (Figure 1H)
to label SVZ cells and not RAs with YFP (Figure S1G). Tamoxifen
fed mice gave rise to both YFP+ SVZ (Figure 1H) and ctx derived
NSs (Figures 1HandS1H).Moreover, YFP+ctxNSswere seenaf-
ter ET-1 strokes both lateral and caudal to the original site, aswell
as after PVD lesions (Figure 1I). Importantly, the frequency of la-
beling in ctxNSs was similar to the frequency of labeling in the
corresponding SVZ (Table S1), supporting the conclusion that
ctxNSs are derived from the SVZ.
To confirm the finding that GFAP+ NSCs were giving rise to
ctxNSs, we took advantage of the GFAP-TK mice (Bush et al.,
1998, 1999) that express herpes simplex virus thymidine kinase
(TK) from the GFAP promoter. In thesemice, proliferating GFAP+
cells will undergo cell death in the presence of ganciclovir (GCV)
(Imura et al., 2003; Morshead et al., 2003). Control (non-TK) mice
that received an ET-1 stroke gave rise to ctxNSs in the presence
of GCV, however, therewas a complete loss of ctxNSs fromET-1
stroke-injured GFAP-TK mice in the presence of GCV (Fig-
ure S1I). These findings are consistent with the conclusion that
ctxNSs are derived from GFAP+ NSCs.
To further demonstrate the SVZ origin of ctxNSs, we used a
well-established SVZ ablation paradigm (Doetsch et al., 1999)
to eliminate proliferating precursors in the SVZ. We predicted
that ablating SVZ precursors would result in a loss of ctxNSs
at 4 days post ET-1 stroke. Cytosine b-D-arabinoside (AraC)
was intraventricularly infused prior to performing the NS assays.
Nestin-CreERT2;tdTomatofl;hGFAP-GFP mice received AraC
for 10 days prior to stroke and for 4 days post stroke (AraC,
10 days+ and 4 days+; Figure 1J (i)). As previously reported
(Doetsch et al., 1999), AraC infusion caused a reduction in the
number of svzNSs and, as predicted, virtually eliminated ctxNS
formation (Figure 1K). We used KI-67 to assess the possibility
that intraventricular AraC administration was depleting the prolif-
erating cells in the stroke-injured cortex and this was accounting
for the loss of NS forming cells from the cortex. Importantly, we
observed KI-67+/GFAP+ cells within the injured cortex demon-
strating that the intraventricular AraC infusion did not eliminate
resident cortical cells that divide post stroke (Figure 1L). Hence,
the loss of ctxNSs was not due to the AraC kill of mitotically
active cells within the lesioned cortex, but rather was the result
of eliminating proliferating SVZ cells.
Previous studies have shown the rapid repopulation of the
SVZ following ablation of the neural precursor pool (Doetsch
et al., 1999; Morshead et al., 1994). We reasoned that AraC
withdrawal at the time of stroke would permit repopulation of
the SVZ and subsequent migration of NSCs to the injured cortex.4_et1_ctx = 3, nP10_et1_ctx = 6, nP4_PVD_ctx = 7, nP10_PVD_ctx = 7, nP4_lat_ctx = 2,
4_PVD_SVZ = 6, nP10_PVD_SVZ = 6, nP4_lat_SVZ = 3, nP10_lat_SVZ = 2, nP4_caud_SVZ = 4,
ice. The picture shows tdTOMATO expression in ctxNSs.
how YFP expression in ctxNSs and SVZNSs.
ensory-motor cortex lesion site and PVD.
one-way ANOVAwith Tukey’s post hoc, F (2,11) = 16.91, data represent ±SEM
zone = SVZ, lateral ventricle = lv, cortex = ctx, corpus callosum = cc, sensory-
tamoxifen = TAM). See also Figure S1 and Table S1.
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Figure 2. Characterization of Migratory SVZ
Cells
(A) Number of ctxNSs (* = p < 0.05, ** = p < 0.01,
*** = p < 0.001, one-way ANOVA with Tukey’s post
hoc, F(9,70)ctx = 7.669, F(9,61)svz = 1.032, data
represent ±SEM (days, d), n0dcx = 3, n4h_cx = 4,
n1d_cx = 7, n2d_cx = 6, n3dcx = 7, n4d_cx = 21, n7d_cx =
7, n10d_cx = 8, and n2mo_cx = 8).
(B) SVZ derived cells migrating to the stroke-
injured cortex in Nestin-CreERT2;YFPfl and Nestin-
CreERT2;tdTomatofl;hGFAP-GFP mice.
(C) EdU labeling paradigm in Nestin-CreERT2;YFPfl
mice.
(D) YFP+EdU+ and YFP+EdU cells in the cortex
and corpus at 2 days and 4 days after stroke. The
inset shows higher magnification of the boxed cell
(n.s. = pctx_2d_vs_4d = 0.6644, unpaired t test, t(8) =
0.4504, data represent ±SEM, n2d_ctx = 5mice, and
n4d_ctx = 6 mice and n.s. = pcc_2d_vs_4d =
0.0883, unpaired t test with Welch’s correction,
t(5) = 2.113, data represent ±SEM, n2d_cc = 4 mice,
and n4d_cc = 6 mice.
(E) YFP+DCX+ and YFP+DCX cells in the cortex
and corpus callosum at 2 days and 4 days after
stroke.
(F) YFP expression in TAM fed, uninjured controls.
The white and yellow insets show higher mag-
nification photos of regions in dashed white and
yellow boxes (cortex = ctx, corpus callosum = cc,
subventricular zone = SVZ, tdTOMATO= TOM, and
tamoxifen = TAM).To test this, AraC was infused for 10 days prior to stroke in the
triple transgenic mice and the NS assay was performed 4 days
later (AraC, 10 days+ and 4 days; Figure 1J (ii)). We observed
the return of svzNSs as predicted, but no concomitant increase
in the number of ctxNSs on day 4 (Figure 1K). Since the lack of
ctxNS formation could be due to a delay in the migration of
SVZ cells to the lesion site following AraC ablation and repopu-
lation, we compared the number of ctxNSs at 7 days post
stroke in AraC treated and untreated (stroke only) wild-type
mice. Interestingly, we found no difference in the numbers of
ctxNSs between these groups (Figure S1J). Notably, when we
compared the number of ctxNSs at 4 and 7 days in AraC
untreated stroke-injured mice, the number of ctxNSs at 7 days
was significantly less than what was observed at 4 days (Fig-
ure 2A). These findings suggest that repopulation of the SVZ
occurs at the expense of migrating SVZ cells to the cortex.
This may be the result of the cortical microenvironment being
less attractive to migrating SVZ precursors at 7 days and/or
the microenvironment prompting their differentiation at the site
of injury.
SVZ Stem Cells Migrate to the Stroke Site and Give Rise
to RAs
Next, we examined the time course of migration of SVZ cells
to the site of injury. We assayed for ctxNS formation followingCell Stem Cell 17, 624–634,ET-1 stroke starting at 4 hr post stroke
and continuing to 2 months post stroke.
As seen in Figure 2A, we observed a
gradual increase in the numbers of ctxNS
from 1 to 4 days. After 4 days, there wasa decrease in the numbers of ctxNSs until 10 days and by
2 months virtually no ctxNSs were detected (one sphere was
formed from the cortex in one of eight animals; Figure 2A).
Consistent with the migration of SVZ cells to the site of injury,
we observed YFP and tdTOMATO labeled cells (Figure 2B) at
2 and 4 days post stroke in the brain parenchyma of the
stroke-injured mice. We characterized the SVZ derived paren-
chymal cells to determine the proliferation dynamics and pheno-
type of migratory YFP+ cells. EdU injections were given to
NestinCreERT2;YFPflmice for 2 or 4 days after stroke (Figure 2C),
and the numbers and locations of YFP+/EdU and YFP+EdU+
cells were assessed. YFP+ cells were seen in both the corpus
callosum and the cortex with no difference in the relative per-
centage of YFP+EdU+ cells at 2 and 4 days post stroke (Fig-
ure 2D). Further, we looked for doublecortin (DCX) expressing
neuroblasts (YFP+/DCX+) en route to, and/or within, the injury
site at 2 and 4 days post stroke and observed a small number
of DCX+ cells in the corpus callosum (Figure 2E) at all times
examined. However, no DCX+ cells were seen in the cortex
at 2 days or 4 days post stroke even at a time of peak ctxNS
formation (Figure 2E). YFP+ cells were never observed in the
parenchyma of control (non-stroked) mice (Figure 2F). To deter-
mine if CSPG4+ cells contribute to cortical NS formation, we
performed the NS assay in Cspg4-DsRed mice 4 days after
stroke. We never observed DSRED+ ctxNSs (0/6 mice). TheseNovember 5, 2015 ª2015 Elsevier Inc. 627
AB C
Figure 3. Migratory SVZ Cells Give Rise to
Reactive Astrocytes at the Lesion Site
(A) Lineage tracing of SVZ cells using Nestin-
CreERT2;YFPfl mice. The YFP+ cells in the paren-
chyma are from 4 days to 2 months after stroke.
(B) Ratio of SVZ derived RAs (YFP+GFAP+/YFPtotal
or TOM+GFP+/TOMtotal) in Nestin-CreERT2;YFPfl
and Nestin-CreERT2;tdTomatofl;hGFAP-GFP mice
(* = p < 0.05, *** = p < 0.001, one-way ANOVA with
Tukey’s post hoc, F(3,19) YFP+GFAP+/YFP
total = 19.87,
data represent ±SEM, n4d = 6 mice, n7d = 7 mice,
n10d =7mice andone-wayANOVAwith Tukey’s post
hoc, F(3,10) Tom+GFP+/Tom
total = 5.5852 data
represent ±SEM, n4d = 3 mice, n7d = 4 mice,
and n10d = 4 mice).
(C) Percentage of multipotent, bipotent, and astro-
cyte only ctxNSs (** = p < 0.01, *** = p < 0.001,
and **** = p < 0.0001) (days, d) (z-test for
independent proportions, z4dvs7dmultipotent = 3.123
z4dvs10dmultipotent=3.9155, z7dvs10dmultipotent=0.8007,
z4dvs7dastrocyte_only = 3.5543 z4dvs10dastrocyte_only =
3.9506, z7dvs10dastrocyte_only = 0.3105, data repre-
sent n4d = 14 NSs, n7d = 12 NSs, and n10d = 15 NSs)
(tdTOMATO = TOM, subventricular zone = SVZ,
lateral ventricle = lv, cortex = ctx, corpus callosum=
cc, and tamoxifen = TAM). See also Figure S2.findings indicate that neither CSPG4+ cells nor migrating YFP+
DCX+ cells give rise to ctxNSs.
Irrespective of ctxNS formation, we consistently observed
SVZ derived YFP+ cells in the cortex of stroke-injured
NestinCreERT2;YFPfl mice from 2 days to 2 months post stroke
(Figures 2B and 3A). We assessed whether the SVZ derived cells
were contributing to injury-induced astrogliosis. The numbers of
GFAP+ astrocytes among SVZ derived cells from the cortex of
Nestin-CreERT2;YFPfl mice was assayed at 4, 7, and 10 days
post stroke. Indeed, we observed a significant increase in the
percentage of SVZ derived RAs (YFP+GFAP+) among total
SVZ derived cells (YFP+) from 4 to 7 days and this increase
was maintained at 10 days post stroke (Figure 3B). At 2 months,
SVZ derived RAs were seen in the astroglial scar (Figure 3A).
To further confirm our findings, we used the NestinCreERT2;
tdTomatofl;hGFAP-GFP mice. Quantification of SVZ derived
cells in the cortex at 4, 7, and 10 days after stroke (Figure S2A)
showed a decrease in the percentage of GFP cells among total
tdTOMATO+ cells (Figure S2B) and an increase in the percent-
age of GFP+ cells among total tdTOMATO+ cells from 4 days
to 7 days (Figure 3B). tdTOMATO+GFP+ cells were positive for
S100b, further confirming astrocyte identity (Figure S2C). Given
that tamoxifen fed control mice also had tdTOMATO signal in
some of the vasculature in the brain (Figure S2D), we may be
underestimating the contribution of SVZ derived tdTOMATO+628 Cell Stem Cell 17, 624–634, November 5, 2015 ª2015 Elsevier Inc.cells to reactive astrogliosis. Together,
these findings show that SVZ derived
cells migrate to the injury site and differ-
entiate into a population of RAs.
We took advantage of the NS assay
to examine the differentiation potential of
ctxNS to test the prediction that ctxNS
would have a higher propensity togenerate astrocyte only clones when isolated at later times
post stroke. Indeed, we found that ctxNSs displayed reduced
multipotency when isolated at 7 and 10 days post stroke (88%
multipotent NSs at 4 days and 13.3% at 10 days post stroke;
Figure 3C). There was a concomitant increase in the number of
ctxNSs producing astrocyte only colonies at later times post
stroke (7% at 4 days and 80% at 10 days) (Figure 3C), Together,
these findings support the hypothesis that SVZ derived cells
migrate to the injury site post stroke and give rise to RAs.
SVZ Derived RAs Can Be Converted into Neurons
We next asked if the SVZ derived RAs could be converted to
neurons. Cultures of RAs were established (S.G., unpublished
data) from the stroke lesioned cortex of tamoxifen treated
Nestin-CreERT2;YFPfl double transgenic mice (Figure 4A). Within
the cultures, the GFAP+ and S100b+ astrocytes were invariably
YFP+, revealing that their origin was from the SVZ and resident
cortical (YFP) astrocytes did not survive in our RA culture
conditions (Figure 4B). Given that we observed small numbers
of DCX+ SVZ derived cells en route to the lesion site post stroke,
and the report by Seidenfaden et al. (2006) suggesting that
neuroblasts can generate glial progeny in vivo, we sought
to determine whether neuroblasts were a source of RAs in our
cultures. We did this by magnetic activated cell sorting (MACS)
PSA-NCAM positive cells (migratory neuroblasts) from the
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Figure 4. Forced Transcription Factor Expression Converts SVZ Derived Reactive Astrocytes to Neurons
(A) Lineage tracing of SVZ derived RAs in vitro using Nestin-CreERT2;YFPfl mice.
(B) YFP expression in GFAP+ and S100b+ astrocytes.
(C) Pictures from ImageStream analysis of MACS sorted RMS, stroke-injured cortex, and uninjured contralateral cortex.
(D) Experimental design for assessing the presence of a residual precursor cell in RA culture conditions.
(E) Numbers of NSs derived from plating cortex and SVZ in RA conditions.
(F) Experimental design for conversion using GFAP-CreERT2;YFPfl mice. The picture shows YFP+ astrocytes after 4-OH-TAM induced recombination.
(G) TUJ1+ neuron after expression of PB-tet-O-Ascl1-T2A-Bfp in YFP labeled astrocytes in vitro.
(legend continued on next page)
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injured cortex and establishing RA cultures from the column
flow through (supernatant). RA cultures could not be established
from the MACS sorted fraction. To validate the MACS sort,
we performed ImageStream analysis on sorted and unsorted
fractions from the injured cortex, the rostral migratory stream
(RMS) (to control for PSA-NCAM+ neuroblasts), and the unin-
jured cortex. ImageStream analysis showed the presence of
PSA-NCAM+ neuroblasts with intense punctate staining (bright
detail intensity) on their surface in the sorted RMS fraction (Fig-
ures 4C and S3A), but not in from the damaged cortex (Figures
4C and S3B) or the uninjured contralateral cortex (Figures 4C
and S3C), consistent with no RA culture establishment from
the sorted cortical fraction and the absence of dcx+ neuroblasts
in the injured cortex at 4 days post injury in tissue sections.
We confirmed that NS forming cells were not contaminating
our RA cultures by plating cells derived from RA cultures in NS
forming conditions (Figure 4D). No NSs were observed from 1-,
2-, 3-, and 4-day RA cultures (Figure 4E).
To examine whether RAs could be converted to neurons,
we established RA cultures from GFAP-CreERT2;YFPfl mice
and forced expression of Ascl1, which alone or in combination
with other factors has been successfully used to convert fibro-
blasts, hepatocytes, and astrocytes to neurons (Heinrich et al.,
2010; Marro et al., 2011; Vierbuchen et al., 2010). We used two
different transfection systems: (1) PB-tet-O-Ascl1-T2A-Bfp,
and (2) CAG-Ascl1-IRES-Dsred (Figure 4F). As predicted, we
found that forced expression of Ascl1 resulted in conversion
of RAs to TUJ1+ neurons (6/7 independent cultures showed
successful conversion; Figure 4G), with efficiencies ranging
from 11%–100% (Figure 4H). We never observed TUJ1+
neurons in control (non-transfected) cultures (0/6 cultures).
TUJ1+ cells co-expressed the mature neuronal marker MAP2
(Figure S3D), indicating that SVZ derived RAs can be converted
to mature neurons by forced expression of a single transcrip-
tion factor, Ascl1.
To test the possibility of converting SVZ derived RAs to
neurons using only Ascl1 in vivo, we transduced GFAP+ RAs
in tamoxifen fed and chased Nestin-CreERT2;YFPfl mice 7 days
post stroke with either an AAV5-Gfap-Ascl1-T2A-mCherry
or an AAV5-Gfap-mCherry control (Figures 4I and S3E). This
paradigm allowed us to assess conversion of GFAP+ RAs that
were derived from the SVZ (YFP+). Interestingly, at 21 days
post stroke, we observed rare YFP+mCHERRY+DCX+ cells (Fig-
ure 4J) and by 35 days YFP+mCHERRY+NEUN+ cells were seen
within the cortex that persisted at 48 days post injury (Figure 4K).
Conversion efficiencies using AAV5-Gfap-Ascl1-T2A-mCherry
were 1.74 ± 1.27% at day 21 and 3.21 ± 1.1% at day 48
(Figure 4L). No NEUN+mCHERRY+ neurons were detected in
AAV5-Gfap-mCherry transduced controls (0/4). Interesting,
in vivo, Ascl1 conversion occurs in cells close to the lesion
core where the host neurons have undergone cell death. These(H) Percent neuronal conversion. The blue dots represent experiments using PB-
dots represent experiments using CAG-Ascl1-IRES-Dsred (n = 3; Tuj1+YFP+DS
(I) Experimental design for in vivo conversion using Nestin-CreERT2;YFPfl mice.
(J) DCX+ neuroblasts after expression of AAV5-Gfap-Ascl1-T2A-mCherry. The h
(K) NeuN+ neurons after expression of AAV5-Gfap-Ascl1-T2A-mCherry. The high
(L) Percent neuronal conversion (n = 4, mCHERRY+DCX+/mCHERRY+; n = 4
droxytamoxifen = 4-OH-TAM, cortex = ctx, rostral migratory stream = RMS, brig
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SVZ derived RAs, albeit at low efficiencies, in vivo.
DISCUSSION
Using a battery of genetic tools, we have shown that SVZ derived
NSCs migrate to the damaged cortex after an injury, where a
subpopulation will give rise to RAs. While previous studies (Buffo
et al., 2008; Shimada et al., 2012) report de-differentiation of
RAs to multipotent self-renewing cells, our work demonstrates
the derivation of cortical NSs from SVZ derived precursors.
Our triple transgenic paradigm allowed simultaneous tracking
of SVZ precursors that express tdTOMATO activated by Nes-
tin-CreERT2 prior to stroke and GFP driven by the GFAP pro-
moter and astrocytes, which would only express GFP driven
by GFAP. No GFP+ only NSs were seen, suggesting that RAs
do not have the potential to formNSs after cortical injury. Rather,
we show that NSCs leave their SVZ niche, migrate to the stroke-
injured cortex, and retain their ability to form multipotent NSs
when isolated in vitro. These findings were confirmed in the
NestinCreERT2;YFPfl mice, where recombination frequencies
in the cortex were similar to what was seen in the SVZ, support-
ing the hypothesis that ctxNSs originated from NSC migration
from the SVZ to the damaged cortex. Further, ablation of dividing
cells in the SVZ eliminated ctxNS formation.
It remains to be determined whether the different findings
regarding the origin of NS forming cells are due to the different
injury models employed. Stroke elicits a robust response in the
SVZ (Arvidsson et al., 2002) and it is not clear if a similar response
is seen after stab wound injury (Synowitz et al., 2006; Tzeng and
Wu, 1999). As such, the different cellular responses observed
in response to injury may underlie the differences reported.
Notably, cortical neurosphere formation has been reported
from resident astrocytes after middle cerebral artery occlusion
(MCAO) (Shimada et al., 2012; Sirko et al., 2013), a more severe
form of stroke that leads to significant cortical and subcortical
lesions (Popp et al., 2009). Hence, the location of the injury (cor-
tex versus striatum) may also play a role in determining the
response of cells in the SVZ. Indeed, we know from previous
studies that the striatum and cortex have distinct responses to
injury (Fuentealba et al., 2015; Magnusson et al., 2014; Nato
et al., 2015; Petit et al., 2001; Xu et al., 2001). We purport that
our findings complement the work of others (Buffo et al., 2008;
Shimada et al., 2012; Sirko et al., 2013) and highlight that both
the location and type of injury play a significant role in the cellular
response of the brain to injury.
Further, comparing the results of our study with those report-
ing a different origin for ctxNSs following injury, one can consider
the experimental techniques employed. For instance, previous
studies that performed fate tracking of astrocytes utilized tamox-
ifen dependent recombination driven by Glast and Gfaptet-O-Ascl1-T2A-Bfp (n = 3; TUJ1+YFP+BFP+ cells/YFP+BFP+ cells). The red
RED+ cells/YFP+DSRED+ cells).
igher magnification is shown of the boxed cell.
er magnification is shown of the boxed cell.
mCHERRY+NEUN+/mCHERRY+) (tamoxifen = TAM, doxycycline = dox, hy-
htfield = BF, and mCherry = CHERRY). See also Figure S3.
c.
promoters (Buffo et al., 2008; Shimada et al., 2012), both of
which are expressed by NSCs in the SVZ (Pastrana et al.,
2009; Platel et al., 2009). Given the considerable overlap be-
tween markers expressed by NSCs and RAs, such as nestin,
GFAP, BLBP, and vimentin (Robel et al., 2011), it is possible
that Glast- and Gfap-mediated Cre recombination occurred in
SVZ NSCs and, thus, SVZ derived cells could have contributed
to the ctxNS formation observed following stab wound or
MCAO injury. The methodologies used to prelabel SVZ cells
and exclude their contribution to ctxNS formation following
stab wound injury or MCAO relied on prelabeling SVZ cells
with lentiviral vectors (Buffo et al., 2008) and DiI labeling (Shi-
mada et al., 2012). However, low frequency of lentiviral labeling
and dilution of the DiI labeling could limit the conclusion that
SVZ cells are not the source of ctxNSs following injury. Notably,
our studies herein do not completely exclude the possibility
that an ectopically labeled astrocyte gave rise to a ctxNS. Hence,
the limitations of the paradigms employed must be considered
when drawing conclusions regarding the origin of ctxNSs.
A number of studies have demonstrated that SVZ precursor
cells also migrate to areas of injury in the adult brain (Arvidsson
et al., 2002; Zhang et al., 2004). We use a number of methodol-
ogies including lineage tracking, transgenic mice, and ablation
paradigms that permit the selective loss of NS forming cells to
show that migration post stroke is not limited to progenitor cells.
We performed a rigorous analysis of the well-delineated proper-
ties of stem cells, multipotentiality, and self-renewal (Potten and
Loeffler, 1990), to demonstrate that SVZ derived NSCs migrate
to the stroke lesion site. Further, immunohistochemistry and
ImageStream analysis revealed that progenitor cells expressing
DCX are not present in the stroke-injured cortex at the time
when we see peak ctxNS formation. Together, these findings
reveal that ctxNSs in the lesion site post stroke are derived
from SVZ NSCs.
Perhaps our most interesting finding is that the NSCs that
migrate to the stroke-injured cortex give rise to RAs. The
SVZ derived RAs that contribute to the gliotic response at later
times post injury add to the heterogeneity observed within the
RA population and may play specific roles in neural repair.
Indeed, a recent study points to specific roles of SVZ derived
RAs in postnatal hypoxia/ischemia; SVZ derived RAs ex-
pressed higher levels of thrombospondin-4 and were respon-
sible for proper scar formation and reduction of microvascular
hemorrhaging (Benner et al., 2013). Moreover, a recent article
showed no evidence for human cortical neurogenesis after
stroke using carbon dating techniques (Huttner et al., 2014)
and may point to an alternate role of the SVZ in producing
RAs after stroke.
A number of studies have shown that developmental signaling
pathways involved in early astrogliogenesis (Bauer et al., 2007;
Yang et al., 2013) are reactivated post injury (Bauer et al.,
2007). Further elucidation of the roles of signaling pathways
such as the janus kinase/signal transducer and activator of
transcription (JAK/STAT), and cytokines such as cardiotrophin-
1 (CT-1), leukemia inhibitory factor (LIF), and ciliary neurotrophic
factor (CNTF) (Yang et al., 2013) will lead to a clearer understand-
ing of the subpopulations of RAs and their involvement in repair
mechanisms after stroke. Further, epigenetic modifications that
allow binding of transcriptional factors to astrocyte promotersCelland activate their expression may be the mechanism whereby
cytokines exert their effect on astrocyte differentiation (Yang
et al., 2013).
The ‘‘lack of success’’ from transplantation paradigms and
endogenous neurogenesis (Dibajnia and Morshead, 2013)
could be the result of astrocyte differentiation favored over
neuronal differentiation. Indeed, Shimada et al. (2012) showed
a loss of neurogenic potential of transplanted cortical derived
neurospheres following transplantation back into the uninjured
brain; only astrocytes and oligodendrocytes were produced.
Nonetheless, the existence of a multipotent cell in the cortex af-
ter stroke offers the possibility of manipulating these cells for
brain repair. Along these lines, Ascl1 was reported to promote
neurogenesis from NSCs (Kim et al., 2009) and astrocytes
(Corti et al., 2012) and is a key regulator of fibroblast to neuron
conversion in vitro (Chanda et al., 2014). We used Ascl1 to
target the progeny of SVZ derived cells and have shown that
it is sufficient to convert these cells to neurons, both in vitro
and in vivo. Hence, SVZ derived RAs may provide a target for
neural repair. The low conversion efficiency of these cells in vivo
may reflect regional/age differences in the brain, as has been
suggested by recent studies targeting endogenous glia for
cellular conversion (Guo et al., 2014; Heinrich et al., 2010,
2011, 2014; Niu et al., 2013; Pollak et al., 2013; Su et al.,
2014). Given the cellular heterogeneity that has been reported,
it is likely that cells in different regions may respond differently
to transcription factors and other stimuli. Cells that migrate to
the cortex, for example, may be intrinsically different or un-
dergo different specification than those that migrate to the
striatum, such that transcription factors used successfully in
one brain region may not directly translate to another. Indeed,
Ascl1 is endogenously upregulated in resident astrocytes in the
striatum after stroke (Magnusson et al., 2014) and has been
used successfully in combination with other transcription-fac-
tors in the striatum (Torper et al., 2013). Ascl1 alone is sufficient
to convert Muller glia into neurogenic progenitors in the retina
(Pollak et al., 2013). More importantly, it remains to be seen if
manipulating these cells will be beneficial or detrimental to tis-
sue regeneration in vivo. A clearer understanding of subpopu-
lations of RAs and their involvement in repair mechanisms
may help us to identify the best cell type for therapeutic cell
conversion.EXPERIMENTAL PROCEDURES
Mice
C57BL/6J and hGFAP-GFP mice (Zhuo et al., 1997) were used to assess
ctxNS formation. GFAP-TK mice (Bush et al., 1998) were used for selective
ablation of GFAP+ NS forming cells. For analysis of the origin of stem cells
in the cortex, Nestin-CreERT2 mice (Imayoshi et al., 2006) were crossed with
tdTomatofl mice (Madisen et al., 2010) and Nestin-CreERT2 mice (Lagace
et al., 2007) were crossed with YFPfl mice (Srinivas et al., 2001), resulting in
Nes-CreERT2;tdTomatofl and Nestin-CreERT2;YFPfl mice. Nestin-CreERT2;
tdTomatofl mice were crossed to hGFAP-GFP mice, resulting in Nestin-
CreERT2;tdTomatofl;hGFAP-GFP mice. In addition, Cspg4-DsRed mice
(Zhu et al., 2008) were used. For RA conversion experiments, GFAP-CrERT2
mice (Casper et al., 2007) were crossed to YFPfl transgenic mice, resulting in
GFAP-CreERT2;YFPfl transgenic mice.
Experiments were conducted according to protocols approved by the
Toronto Centre for Phenogenomics and the Department of Comparative
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ET-1 Stroke
1 ml of 400 pmolar ET-1 (Calbiochem) was injected stereotaxically into the cor-
tex at 0.6 anterior-posterior (AP), 2.25 medial-lateral (ML), 1 dorsal-ventral
(DV) (sensory-motor cortex coordinates);1.7 AP, +4 ML,3 DV (lateral coor-
dinates); or2.3 AP, +2 ML,0.5 DV (caudal coordinates), relative to bregma.
PVD Stroke
PVD strokes were induced by removing the skull and dura in the region bound
by 0.5 to +2.5 AP and +0.5 to 3 ML, relative to bregma. A saline-soaked cotton
swab was used to remove pial vessels.
Tamoxifen Induction
Animals were fed tamoxifen food (0.5% TAM and 5% sucrose; Harlan) for
2 weeks followed by a chase period of 2–3 weeks.
Adeno Associated Viral Injections
1 ml of AAV5-Gfap-Ascl1-T2A-mCherry or AAV5-Gfap-mCherry particles (Vec-
torBioLabs) were injected into the cortex of NestinCreERT2;YFPfl mice 7 days
post stroke.
NS Culture
NSs were cultured as previously described (Coles-Takabe et al., 2008;
Tropepe et al., 1997). Cells were plated at clonal density (5 cells/mL).
RA Culture and Conversion
The cortex was dissected from GFAP-CreERT2;YFPfl mice. Cells were plated
in astrocyte media with 1 mM 4-OH-TAM. After 7 days, cells were transfected
with PBase, PB-CAG-rtTA (Woltjen et al., 2009), and PBtetO-Ascl1-T2A-Bfp
or CAG-Ascl1-IRES-Dsred using HD Fugene (Roche). Themedia was changed
to N2B27. For PBtetO-Ascl1-T2A-Bfp expression, 1,500 ng/mL dox was
added.
MACS and ImageStream Analysis
Cells were stained with anti-PSA-NCAM-PE (Miltenyi Biotech) and MACS
sorted. For ImageStream analysis, cells were stained with a fixable cell viability
dye (FVD eFluor 780; eBioscience), anti-PSA-NCAM-PE (Miltenyi Biotech), or
a mouse IgM-PE control (Miltenyi Biotech), MACS sorted and stained with
Hoescht (BD Biosciences). Cells were analyzed with an Amnis Image-
StreamTM Mark II imaging flow cytometer (Amnis) and compensated image
files were analyzed using IDEAS analysis software (Amnis).
Statistical Analysis
All experiments were conducted blind, using a numbering system. F tests were
used to compare variance between groups. Unpaired two-tailed t tests or un-
paired two-tailed t tests with Welch’s correction (for unequal variance) were
used for comparisons between two groups. A one-factor ANOVA was used
followed by post hoc analysis (Tukey’s or Dunnet’s test) for comparisons be-
tween three or more groups. Comparison of percentages between groups
was done using two sample z-tests for individual proportions. Differences
were considered significant at p < 0.05. Values are presented as mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
three figures, and one table and can be found with this article online at
http://dx.doi.org/10.1016/j.stem.2015.08.002.
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